Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 22 | 2025 | 875 | 3.190 |
Why?
|
| Heart Failure | 19 | 2025 | 2387 | 1.850 |
Why?
|
| Heart-Assist Devices | 15 | 2025 | 1084 | 1.800 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2024 | 175 | 0.830 |
Why?
|
| Pulmonary Heart Disease | 1 | 2022 | 4 | 0.750 |
Why?
|
| Heart Defects, Congenital | 6 | 2025 | 1867 | 0.730 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2024 | 158 | 0.710 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 87 | 0.700 |
Why?
|
| Child | 44 | 2025 | 25791 | 0.670 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 203 | 0.630 |
Why?
|
| Organ Transplantation | 1 | 2022 | 181 | 0.620 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 107 | 0.600 |
Why?
|
| Tracheostomy | 1 | 2020 | 201 | 0.570 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 180 | 0.550 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 308 | 0.540 |
Why?
|
| Retrospective Studies | 32 | 2025 | 17352 | 0.530 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 464 | 0.530 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 248 | 0.520 |
Why?
|
| Clostridium Infections | 1 | 2019 | 248 | 0.500 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 49 | 0.490 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 110 | 0.470 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1205 | 0.460 |
Why?
|
| Stroke Volume | 2 | 2023 | 534 | 0.440 |
Why?
|
| Cardiomyopathies | 4 | 2022 | 508 | 0.430 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 206 | 0.410 |
Why?
|
| Postoperative Complications | 4 | 2022 | 3139 | 0.380 |
Why?
|
| Humans | 52 | 2025 | 132327 | 0.360 |
Why?
|
| Graft Rejection | 6 | 2024 | 560 | 0.350 |
Why?
|
| Child, Preschool | 17 | 2025 | 14843 | 0.340 |
Why?
|
| Adolescent | 20 | 2025 | 20522 | 0.340 |
Why?
|
| Infant | 13 | 2025 | 13184 | 0.280 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2021 | 143 | 0.280 |
Why?
|
| Female | 25 | 2025 | 70818 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2024 | 1076 | 0.270 |
Why?
|
| Male | 24 | 2025 | 65037 | 0.270 |
Why?
|
| Shock, Cardiogenic | 2 | 2024 | 212 | 0.230 |
Why?
|
| Methylprednisolone | 1 | 2025 | 97 | 0.220 |
Why?
|
| Treatment Outcome | 11 | 2025 | 13012 | 0.210 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 171 | 0.200 |
Why?
|
| Allografts | 1 | 2024 | 196 | 0.200 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 44 | 0.200 |
Why?
|
| Registries | 3 | 2025 | 1583 | 0.200 |
Why?
|
| Myocarditis | 1 | 2024 | 130 | 0.200 |
Why?
|
| Transplants | 1 | 2022 | 36 | 0.190 |
Why?
|
| Young Adult | 8 | 2024 | 9936 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 303 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2023 | 518 | 0.190 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2024 | 268 | 0.190 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8563 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2024 | 5146 | 0.190 |
Why?
|
| Warfarin | 1 | 2023 | 127 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.180 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 35 | 0.180 |
Why?
|
| Hemolysis | 1 | 2021 | 116 | 0.180 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 672 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2021 | 274 | 0.170 |
Why?
|
| Prognosis | 6 | 2024 | 5008 | 0.170 |
Why?
|
| Heart Rate | 1 | 2023 | 572 | 0.170 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2020 | 43 | 0.170 |
Why?
|
| Patient Selection | 1 | 2024 | 729 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 216 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 263 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 178 | 0.160 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 133 | 0.160 |
Why?
|
| Macrophages | 1 | 2024 | 693 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2022 | 230 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 212 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 217 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 384 | 0.150 |
Why?
|
| Transposition of Great Vessels | 1 | 2020 | 135 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 5403 | 0.150 |
Why?
|
| Risk Factors | 6 | 2024 | 10903 | 0.140 |
Why?
|
| Heart Ventricles | 2 | 2013 | 781 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2023 | 512 | 0.140 |
Why?
|
| Capillaries | 1 | 2018 | 71 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 252 | 0.140 |
Why?
|
| Heart | 2 | 2022 | 701 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2022 | 1229 | 0.130 |
Why?
|
| Lung Transplantation | 1 | 2021 | 336 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1526 | 0.130 |
Why?
|
| Length of Stay | 2 | 2020 | 1378 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 529 | 0.130 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 134 | 0.130 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 335 | 0.130 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 271 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1153 | 0.130 |
Why?
|
| Graft Survival | 3 | 2024 | 475 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 423 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2016 | 61 | 0.120 |
Why?
|
| Recurrence | 1 | 2019 | 1458 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 1068 | 0.120 |
Why?
|
| Age Factors | 1 | 2021 | 2929 | 0.110 |
Why?
|
| Diastole | 1 | 2015 | 179 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 667 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 172 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 79 | 0.110 |
Why?
|
| Adult | 10 | 2024 | 31602 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3852 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 288 | 0.110 |
Why?
|
| Cardiac Volume | 1 | 2013 | 18 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 191 | 0.100 |
Why?
|
| Prevalence | 1 | 2020 | 2664 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2015 | 494 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 41 | 0.100 |
Why?
|
| United States | 3 | 2024 | 11617 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1103 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1829 | 0.090 |
Why?
|
| Contrast Media | 1 | 2016 | 508 | 0.090 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 119 | 0.090 |
Why?
|
| Survival Rate | 3 | 2025 | 2186 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 27 | 0.090 |
Why?
|
| Waiting Lists | 2 | 2024 | 236 | 0.090 |
Why?
|
| Cardiac Catheterization | 3 | 2023 | 665 | 0.090 |
Why?
|
| Transplant Recipients | 2 | 2023 | 225 | 0.080 |
Why?
|
| Hospitalization | 3 | 2024 | 1894 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2229 | 0.080 |
Why?
|
| Myocardium | 2 | 2024 | 912 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 545 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2022 | 860 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2023 | 607 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 982 | 0.060 |
Why?
|
| Obesity | 2 | 2021 | 2406 | 0.060 |
Why?
|
| Heart-Lung Transplantation | 1 | 2024 | 24 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1165 | 0.050 |
Why?
|
| Gadolinium | 1 | 2024 | 116 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 2303 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 373 | 0.050 |
Why?
|
| Cicatrix | 1 | 2024 | 123 | 0.050 |
Why?
|
| Time Factors | 2 | 2025 | 6460 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 49 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 43 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 30 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 198 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 103 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 36 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 33 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 466 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 52 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 49 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 47 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2021 | 1707 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 156 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 102 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 75 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 353 | 0.040 |
Why?
|
| Antibodies | 1 | 2022 | 364 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 293 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 216 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 214 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 281 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1176 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 400 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 778 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 87 | 0.040 |
Why?
|
| Benchmarking | 1 | 2020 | 137 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1287 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2019 | 3419 | 0.040 |
Why?
|
| Miniaturization | 1 | 2019 | 26 | 0.040 |
Why?
|
| Echocardiography | 2 | 2018 | 1126 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 412 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 471 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1377 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 301 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 485 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 798 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 508 | 0.040 |
Why?
|
| Sternotomy | 1 | 2018 | 43 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 657 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 215 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 513 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 669 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 823 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 32 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 41 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3710 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 760 | 0.030 |
Why?
|
| Biomarkers | 1 | 2024 | 3389 | 0.030 |
Why?
|
| Aorta | 1 | 2018 | 554 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 117 | 0.020 |
Why?
|
| Exercise Test | 1 | 2011 | 255 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 2150 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 988 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1442 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 18623 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1719 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 28870 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 35138 | 0.010 |
Why?
|